Literature DB >> 8532712

Transforming growth factor-beta s in mammary tumorigenesis: promoters or antipromoters?

L M Wakefield1, J J Letterio, A G Geiser, K C Flanders, J O'Shaughnessy, A B Roberts, M B Sporn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8532712

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN: 0361-7742


× No keyword cloud information.
  5 in total

1.  Lack of fetuin-A (alpha2-HS-glycoprotein) reduces mammary tumor incidence and prolongs tumor latency via the transforming growth factor-beta signaling pathway in a mouse model of breast cancer.

Authors:  Bobby Guillory; Amos M Sakwe; Margret Saria; Pamela Thompson; Christine Adhiambo; Rainelli Koumangoye; Billy Ballard; Awadh Binhazim; Cecil Cone; Willi Jahanen-Dechent; Josiah Ochieng
Journal:  Am J Pathol       Date:  2010-09-16       Impact factor: 4.307

2.  Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta.

Authors:  X H Feng; X Lin; R Derynck
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

Review 3.  TGF-beta3 and cancer: a review.

Authors:  H G Laverty; L M Wakefield; N L Occleston; S O'Kane; M W J Ferguson
Journal:  Cytokine Growth Factor Rev       Date:  2009-08-04       Impact factor: 7.638

Review 4.  Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models.

Authors:  L M Wakefield; Y A Yang; O Dukhanina
Journal:  Breast Cancer Res       Date:  2000-02-21       Impact factor: 6.466

5.  Identification of genetic loci that control mammary tumor susceptibility through the host microenvironment.

Authors:  Pengju Zhang; Alvin Lo; Yurong Huang; Ge Huang; Guozhou Liang; Joni Mott; Gary H Karpen; Eleanor A Blakely; Mina J Bissell; Mary Helen Barcellos-Hoff; Antoine M Snijders; Jian-Hua Mao
Journal:  Sci Rep       Date:  2015-03-09       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.